
 [
{
"symbol" : "530199",
"exchange" : "BOM",
"id": "715565",
"t" : "530199",
"e" : "BOM",
"name" : "Themis Medicare Ltd"
, "f_reuters_url" : "http:\u002F\u002Fstocks.us.reuters.com\u002Fstocks\u002Fratios.asp?rpc=66\u0026symbol=",
"f_recent_quarter_date" : "",
"f_annual_date" : "",
"f_ttm_date" : "",
"financials" :
[{
"f_type" : "Income\u0026nbsp\u003BStatement"
,"url" : "http:www.google.comfinance?fstype=ii&q=BOM:530199"
,"f_figures" :
[
]
},
{
"f_type" : "Balance\u0026nbsp\u003BSheet"
,"url" : "http:www.google.comfinance?fstype=bi&q=BOM:530199"
,"f_figures" :
[
]
},
{
"f_type" : "Cash\u0026nbsp\u003BFlow"
,"url" : "http:www.google.comfinance?fstype=ci&q=BOM:530199"
,"f_figures" :
[
]
}],
"kr_recent_quarter_date" : "Q1 (Mar \u002717)",
"kr_annual_date" : "2017",
"kr_ttm_date" : "TTM",
"keyratios" :
[
{
"title" : "Net profit margin",
"recent_quarter" : "2.91%",
"annual" : "7.66%",
"ttm" : "7.66%"
},
{
"title" : "Operating margin",
"recent_quarter" : "8.47%",
"annual" : "11.28%",
"ttm" : "11.28%"
},
{
"title" : "EBITD margin",
"recent_quarter" : "",
"annual" : "15.23%",
"ttm" : "15.23%"
},
{
"title" : "Return on average assets",
"recent_quarter" : "",
"annual" : "6.45%",
"ttm" : "6.45%"
},
{
"title" : "Return on average equity",
"recent_quarter" : "",
"annual" : "20.04%",
"ttm" : "20.04%"
}
]
, "c" : "+11.75",
"l" : "545.00",
"cp" : "2.20",
"ccol" : "chg",
"op" : "545.00",
"hi" : "545.00",
"lo" : "533.60",
"vo" : "274.00",
"avvo" : "",
"hi52" : "798.10",
"lo52" : "380.00",
"mc" : "5.12B",
"pe" : "25.94",
"fwpe" : "",
"beta" : "",
"eps" : "21.01",
"dy" : "",
"ldiv" : "",
"shares" : "9.30M",
"instown" : "",
"eo":""
, "related" : [
{
"id" : "715565",
"name" : "Themis Medicare Ltd",
"t" : "530199",
"e" : "BOM",
"l" : "545.00",
"c" : "+11.75",
"mc" : "5.12B",
"cp" : "2.20",
"ccol" : "chg"
}
,
{
"id" : "1984268",
"name" : "Surya Pharmaeutical Ltd",
"t" : "SURYAPHARM",
"e" : "NSE",
"l" : "1.40",
"c" : "",
"mc" : "60.83M",
"cp" : "",
"ccol" : ""
}
,
{
"id" : "6809657",
"name" : "Aarti Drugs Ltd.",
"t" : "AARTIDRUGS",
"e" : "NSE",
"l" : "608.05",
"c" : "-5.10",
"mc" : "14.53B",
"cp" : "-0.83",
"ccol" : "chr"
}
,
{
"id" : "15490987",
"name" : "TTK Health Care Ltd",
"t" : "TTKHLTCARE",
"e" : "NSE",
"l" : "1,251.00",
"c" : "-10.50",
"mc" : "9.65B",
"cp" : "-0.83",
"ccol" : "chr"
}
,
{
"id" : "1188812",
"name" : "Emami Ltd",
"t" : "EMAMILTD",
"e" : "NSE",
"l" : "1,105.50",
"c" : "+33.30",
"mc" : "250.26B",
"cp" : "3.11",
"ccol" : "chg"
}
,
{
"id" : "15510678",
"name" : "Apollo Hospitals Enterprise Limited",
"t" : "APOLLOHOSP",
"e" : "NSE",
"l" : "1,236.50",
"c" : "+4.90",
"mc" : "171.55B",
"cp" : "0.40",
"ccol" : "chg"
}
,
{
"id" : "8321085",
"name" : "Godavari Drugs Ltd",
"t" : "530317",
"e" : "BOM",
"l" : "35.65",
"c" : "+1.65",
"mc" : "268.46M",
"cp" : "4.85",
"ccol" : "chg"
}
,
{
"id" : "201905350059104",
"name" : "Mercury Laboratories Ltd",
"t" : "538964",
"e" : "BOM",
"l" : "420.25",
"c" : "-5.00",
"mc" : "504.30M",
"cp" : "-1.18",
"ccol" : "chr"
}
,
{
"id" : "7489710",
"name" : "Brooks Laboratories Ltd",
"t" : "BROOKS",
"e" : "NSE",
"l" : "94.00",
"c" : "-0.30",
"mc" : "1.51B",
"cp" : "-0.32",
"ccol" : "chr"
}
,
{
"id" : "7222829",
"name" : "Makers Laboratories Ltd",
"t" : "506919",
"e" : "BOM",
"l" : "81.35",
"c" : "+1.15",
"mc" : "406.07M",
"cp" : "1.43",
"ccol" : "chg"
}
,
{
"id" : "11460194",
"name" : "Nutraplus India Ltd",
"t" : "524764",
"e" : "BOM",
"l" : "36.00",
"c" : "0.00",
"mc" : "1.23B",
"cp" : "0.00",
"ccol" : "chb"
}
]
, "summary" : [{
"address": "11\u002F12 Udyog Nagar S V Road, Goregaon (West), MUMBAI, 400104, India",
"phone": "+91-22-67607080",
"fax": "+91-22-28746621",
"url": "http:\u002F\u002Fwww.themismedicare.com\u002F",
"overview" : "Themis Medicare Limited is a pharmaceutical company. The Company is engaged in manufacturing pharmaceuticals and medicinal chemicals. The Company focuses on therapeutic areas, including anti-tuberculosis, anti-malarial, cardiology, pain management, anti-infectives, haematinics, health and nutrition. The Company\u0027s active pharmaceutical ingredients (APIs) include Simvastatin, Ethambutol, Artemether, Artesunate, Arteether and Di Methyl Isosorbide. The Company\u0027s formulations include original products, new drug delivery systems (NDDS), dietary supplements and others. Its original products include Emal injection, Sepgard Gel, Sepgard Mouth Gargle and Sepgard Solution. The Company\u0027s NDDS include Injection Diclofenac Sodium, Gel Diclofenac Diethylamine, Emal Prefilled Injection, Etojet injection and Injection Aceclofenac. The Company offers a range of dietary supplements, which include Gummy Vita (Kids), Gummy Cal (Kids) and Gummy Cal (Adults)."
} ]
, "management" : [
{
"name" : "Sachin Dinesh Patel Ph.D.",
"age" : "42",
"title" : "Chief Executive Officer, Managing Director, Executive Director"
}
,
{
"name" : "Dinesh Shantibhai Patel Ph.D.",
"age" : "68",
"title" : "Executive Vice Chairman of the Board"
}
,
{
"name" : "Tushar J. Dalal",
"title" : "Chief Financial Officer"
}
,
{
"name" : "Sangameshwar Lyer",
"title" : "Compliance Officer, Company Secretary"
}
,
{
"name" : "Jayshree Dinesh Patel",
"age" : "66",
"title" : "Whole Time Director"
}
,
{
"name" : "Luis Dias",
"title" : "Executive Management Board Member - API - Business Co-ordinator"
}
,
{
"name" : "Shashikant P. Kurani Ph.D.",
"title" : "Executive Management Board Member - Regulatory \u0026 Scientific Affairs"
}
,
{
"name" : "T. Damodar Reddy",
"title" : "Executive Management Board Member - API - Business Biotech"
}
,
{
"name" : "Hoshang Noshirwan Sinor",
"age" : "70",
"title" : "Independent Non-Executive Chairman of the Board"
}
,
{
"name" : "Gabor M. Gulasci",
"title" : "Additional Director"
}
]
,"moreresources" : [
]
}]
